Cognitive performance optimization

01Overview and value chain#

Markers EC: none — DSHEA dietary-supplement framework | OECD: biotech-health, digital-bioeconomy | Regulator: FDA (USA)

Cognitive performance optimization in this article means biomarker- or genetic-panel-guided cognitive supplementation specifically, not the broader generic nootropic-supplement market. A genetic or biomarker test result guides a personalized supplement recommendation targeting cognitive function — mental clarity, focus, or overnight brain recovery — rather than a one-size-fits-all formula. This is a narrower slice of the broader personalized-nutrition and biomarker-guided wellness space already covered on this site: two other genuinely biomarker-guided platforms (InsideTracker, Viome) were investigated but excluded from this table because they are already tabled on this site’s sports-bioeconomy and personalized-nutrition articles respectively, and re-tabling them here would double-count the same companies under an overlapping category rather than surface a genuinely distinct vendor. The two vendors confirmed specifically for this narrower cognitive-optimization slice are both real, on-topic, and not already tabled elsewhere.

The key directions of cognitive performance optimization are:

1. Pharmacogenomic (PGx) testing for mental-health guidance: genetic panels informing medication and supplement guidance specific to mental-health and cognitive outcomes.
2. Daytime cognitive performance supplementation: supplement formulations targeting focus, mental clarity, and cognitive performance during waking hours.
3. Overnight brain-recovery supplementation: a distinct formulation strategy targeting cognitive recovery and restoration during sleep, rather than daytime performance.
4. Genetic-panel-guided personalization: using an individual’s genetic test results, rather than a generic formula, to guide the specific supplement recommendation.

Sectoral value chain#

[Genetic/biomarker testing] ──> [Result interpretation] ──> [Personalized recommendation] ──> [Supplement formulation]
                                                                       │
                                                             (daytime/overnight targeting)
                                                                       │
                                                                       ▼
[Cognitive outcome tracking] <─── [Supplement delivery] <────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Pharmacogenomic interpretation science: the scientific basis for connecting a specific genetic variant to a mental-health or cognitive-function implication.
• Dual-formulation strategy: engineering separate daytime-performance and overnight-recovery supplement lines rather than a single generic cognitive formula.
• Personalization algorithms: systems translating an individual’s test results into a specific, individualized product recommendation.

02US#

The US has both confirmed vendors in this narrower category.

Pharmacogenomic mental-health guidance, daytime/overnight cognitive supplementation#

• Genomind: offers the MentalHealthMap and Genomind PGx Test products, confirmed via the company’s own solution pages, providing pharmacogenomic testing tied to mental-health supplement and medication guidance.
• BioAdaptives (MyndSystem): launched the MyndSystem platform in 2026, confirmed via the company’s own press release describing it as the first supplement platform designed to support both daytime cognitive performance and overnight brain recovery.

03CN#

No Chinese vendor with a dedicated, confirmed biomarker-guided cognitive-optimization product was found on a live screen.

No confirmed dedicated vendor#

• Market context: this article found no Chinese company with confirmed, on-topic evidence of a genetic-panel or biomarker-guided cognitive-supplement product.
• Reopen condition: if a Chinese vendor selling a confirmed biomarker-guided cognitive-optimization product surfaces on a future screen, this section should be revised and the company added to the table.

04EU#

No EU vendor with a dedicated, confirmed biomarker-guided cognitive-optimization product was found on a live screen.

No confirmed dedicated vendor#

• Market context: this article found no EU company with confirmed, on-topic evidence of a genetic-panel or biomarker-guided cognitive-supplement product.
• Reopen condition: if an EU vendor selling a confirmed biomarker-guided cognitive-optimization product surfaces on a future screen, this section should be revised and the company added to the table.

05Leading companies and research institutes#

06Tech stack and innovations#

The category’s technology centers on connecting a genetic or biomarker test result to a specific, individualized cognitive-supplement recommendation, distinct from a generic nootropic formula.

1. Pharmacogenomic mental-health mapping:
   • Genomind’s MentalHealthMap and PGx Test translate genetic variant data into mental-health and cognitive-function-relevant guidance, a more clinically-grounded approach than a generic supplement quiz.
2. Dual-timing supplement design:
   • BioAdaptives’ MyndSystem explicitly separates daytime cognitive-performance formulation from overnight brain-recovery formulation, treating these as distinct physiological targets rather than a single all-purpose cognitive product.
3. Category boundary discipline:
   • This article’s scope deliberately excludes broader biomarker-guided wellness platforms (InsideTracker, Viome) that are genuinely biomarker-guided but already own their own distinct articles on this site — a reminder that “cognitive optimization” and “general biomarker-guided wellness” are related but not identical markets.

07Value chains and production pipelines#

Industrial pipeline of a biomarker-guided cognitive supplement (US FDA DSHEA framework)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Genetic/biomarker testing │ ───> │ 2. Result interpretation   │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Supplement formulation   │ <─── │ 3. Personalized recommendation │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Supplement delivery      │ ───> │ 6. Cognitive outcome tracking │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Genetic/biomarker testing

The customer takes a genetic panel (Genomind PGx Test) or provides another biomarker sample relevant to cognitive/mental-health function.

Stage 2: Result interpretation

The test results are interpreted against known gene-function or biomarker-outcome associations, as with Genomind’s MentalHealthMap.

Stage 3: Personalized recommendation

A specific supplement recommendation is generated from the interpreted profile, distinct from a one-size-fits-all cognitive formula.

Stage 4: Supplement formulation

The recommended formulation is manufactured, targeted either to daytime cognitive performance or overnight brain recovery, as in BioAdaptives’ dual-line approach.

Stage 5: Supplement delivery

The formulated supplement is delivered to the customer for regular use.

Stage 6: Cognitive outcome tracking

The customer’s cognitive outcomes are tracked over time to assess whether the recommendation is working and refine it for future cycles.